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Because a protective barrier is essential for life, the
development of the epidermis and stratum corneum must
be completed prior to birth. The epidermal permeability
barrier is comprised of corneocytes embedded in a lipid
enriched matrix. Recent studies from our laboratory,
using an explant model of fetal rat skin development that
closely parallels in utero development, have shown that
hormones and other activators of members of the nuclear
receptor family regulate permeability barrier ontogenesis
by stimulating lipid metabolism and the formation of
the extracellular lipid lamellae. Using this model we
sought to determine whether these hormones and nuclear
activators also regulate keratinocyte differentiation dur-
ing fetal development. Profilaggrin/filaggrin and loricrin
expression, assessed by in situ hybridization and by
immunohistochemistry, were progressively increased
during epidermal ontogenesis. Whereas profilaggrin/fil-
aggrin and loricrin were not expressed at day 17 of
gestation, by day 19 both were present in the upper layers
of the epidermis and both became still more abundant
by day 21. These developmental changes also occurred
in fetal skin explants cultured in vitro for 4 d, although
The vectorial differentiation of keratinocytes in the epi-dermis is a multistep process that culminates incornification and in the establishment of the permeabilitybarrier to water transit (Fuchs, 1990; Jackson et al, 1993;Eckert et al, 1997). Cornification is characterized by the
extensive cross-linking of loricrin and other structural proteins to form
the cornified envelope (Fuchs, 1990; Mehrel et al, 1990; Steven et al,
1990; Hohl and Roop, 1993; Jackson et al, 1993; Eckert et al,
1997). The immediate precursors of corneocytes are the terminally
differentiating keratinocytes of the stratum granulosum. These cells are
characterized by the presence of keratohyalin granules, containing
abundant quantities of profilaggrin and numerous epidermal lamellar
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the expression levels did not appear as robust as in utero.
Whereas neither profilaggrin/filaggrin nor loricrin were
expressed in control explants cultured for 2 d, they were
seen in explants treated with either thyroid hormone,
glucocorticoids, or estrogens. In contrast, dihydrotesto-
sterone treatment delayed the expression of profilaggrin/
filaggrin and loricrin. Moreover, both clofibrate, a peroxi-
some proliferator-activated receptor-α ligand, and
juvenile hormone III, a farnesoid X-activated receptor
activator, markedly accelerated fetal epidermal differenti-
ation, stimulating both profilaggrin/filaggrin and loricrin
expression. Our results demonstrate that several hor-
mones and activators of nuclear hormone receptors regu-
late epidermal differentiation during fetal development,
affecting key constituents of both keratohyalin granules
and the cornified envelope. Thus, a variety of ligands/
activators of nuclear receptors accelerate not only per-
meability barrier ontogenesis, but also the expression of
structural proteins essential for stratum corneum forma-
tion. Key words: dihydrotestosterone/estrogen/filaggrin/FXR/
glucocorticoids/loricrin/PPARα/thyroid hormone. J Invest
Dermatol 111:429–433, 1998
bodies (Dale et al, 1985, 1993; Haydock and Dale, 1990; Elias and
Menon, 1991). Following the secretion of the lipid and enzyme
contents of lamellar bodies, a series of structural transformations leads
to the formation of mature lamellar unit membranes in the interstices
of the stratum corneum, resulting in the formation of the cutaneous
permeability barrier (Jackson et al, 1993; Elias and Menon, 1991).
Because a competent barrier is essential for survival in a terrestrial
environment, the development of the epidermis and stratum corneum
is completed prior to term. Previous studies from our laboratory
showed that a competent permeability barrier appears between days
20 and 21 of gestation (term 5 22 d) in rats (Aszterbaum et al, 1992).
Moreover, in an explant model of fetal rat skin development, which
closely parallels in utero development, we showed that hormones and
other ligands of members of the nuclear hormone receptor family
regulate permeability barrier ontogenesis (Aszterbaum et al, 1993;
Hanley et al, 1996a, b, 1997b, c). Specifically, thyroid hormone,
glucocorticoids, and estrogen accelerate, whereas dihydrotestosterone
delays permeability barrier formation (Hanley et al, 1996a, b). Further-
more, very recent studies demonstrated that activators of both
peroxisome proliferator-activated receptor (PPAR)-α and farnesoid X-
activated receptor (FXR) also accelerate permeability barrier develop-
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ment in fetal rat skin explants (Hanley et al, 1997b). PPARα and FXR
are nuclear hormone receptors that form heterodimers with RXR
(Forman et al, 1995; Mangelsdorf et al, 1995). PPARα is activated by
fatty acids and various drugs, such as clofibrate, and regulates numerous
aspects of lipid metabolism (Schoonjans et al, 1996). FXR is activated
by farnesol that is formed from intermediates in the cholesterol
biosynthetic pathway, and by juvenile hormone III (Forman et al,
1995). The genes regulated by FXR have not yet been defined.
Although these studies demonstrate that the ontogenesis of the
permeability barrier is regulated by hormones and PPARα and FXR
activators, their importance in the regulation of the expression of
structural proteins remains unknown. Recently, Bickenbach et al (1995)
showed a parallel expression of loricrin with permeability barrier
formation during fetal epidermal development in the mouse. These
findings suggest that both ontogenesis of the extracellular lipid matrix
of the stratum corneum, and cornified envelope formation may occur
simultaneously. Yet, in intrauterine growth-retarded fetal rats the
expression of cornification markers is decreased (Hoat et al, 1990),
whereas the formation of the permeability barrier proceeds normally
(Williams et al, 1993). Additionally, in mice who overexpress an
retinoic acid receptor dominant-negative mutant in the suprabasal
epidermis, keratinocyte cornification proceeds normally, but the forma-
tion of the extracellular lipid lamellae that comprise the permeability
barrier is impaired (Imakado et al, 1995). Thus, these observations
suggest that expression of structural proteins and permeability barrier
formation may be regulated independently.
In this study we determined whether developmental events of
keratinocyte differentiation are coordinately regulated with the estab-
lishment of the permeability barrier. We studied the effect of hormones
(thyroid hormone, glucocorticoids, estrogen, and dihydrotestosterone)
and activators of PPARα (clofibrate) and FXR (juvenile hormone III)
on the expression of filaggrin and loricrin. Our results demonstrate
that these hormones and nuclear receptor activators regulate not only
permeability barrier formation, but also the expression of key structural
proteins of epidermal differentiation.
MATERIAL AND METHODS
Organ culture Timed pregnant Sprague-Dawley rats (plug date 5 day 0)
were obtained from Simonsen Laboratories (Gilroy, CA). A total of nine litters
were used in this study. To establish the sequence of epidermal differentiation
during in utero development, fetal skin was collected from fetuses on days 17,
19, and 21 of pregnancy. Tissue samples from at least five animals were used
for each data point. For in vitro studies, full-thickness flank skin of 17 d old
embryos was excised and incubated dermal side down on collagen membrane
inserts (Transwell-COL, Costar, Cambridge, MA) for 2–4 d, in serum- and
growth factor-free M199 tissue culture media, as described previously (Hanley
et al, 1996a, b, 1997b). At the beginning of the culture dexamethasone
(10 nM final concentration), thyroid hormone (10 nM final concentration),
diethylstilbestrol (100 nM final concentration), dihydrotestosterone (100 nM
final concentration), clofibrate (p-chlorophenoxyisobutyric acid, 300 µM final
concentration), or juvenile hormone III (250 µM final concentration), all
purchased from Sigma (St. Louis, MO), were added to the culture medium.
Clofibrate was added to the medium bound to 0.5% bovine serum albumin.
Dexamethasone, diethylstilbestrol, and dihydrotestosterone were dissolved in
ethanol. Thyroid hormone and juvenile hormone III were dissolved in
dimethylsulfoxide. Control explants were incubated in the presence of the
appropriate vehicle.
The tissue samples were fixed in 4% formaldehyde (freshly prepared from
paraformaldehyde) in phosphate-buffered saline for 24 h and were embedded
in paraffin. Sections were collected on positively charged microscope slides
(SuperfrostPlus, Fisher Scientific, Pittsburgh, PA) and stained with hematoxylin
and eosin or used for in situ hybridization or immunohistochemistry. Photomic-
rographs were taken with a Microphot FX (Nikon) microscope, using a 203
planapochromate objective.
In situ hybridization Digoxigenin-labeled RNA probes to detect profilaggrin
and loricrin mRNA were made from linearized cDNA sequences as templates
(Haydock and Dale, 1990; Mehrel et al, 1990), using reagent supplied by
Boehringer (Indianapolis, IN). The hybridization of the DIG-labeled probes
(Jowett, 1997) was detected by an anti-DIG antibody, conjugated to alkaline
phosphatase (Boehringer). The activity of the alkaline phosphatase was revealed
with BCIP/NBT substrate. A set of controls was used to establish the specificity
of the hybridization. Probes of sense orientation served as controls to ensure
Figure 1. Profilaggrin/filaggrin and loricrin expression increases during
in utero development of fetal rats. Hematoxylin and eosin stained sections
of the epidermis at day 17 (A), day 19 (B), and day 21 (C). Epidermal expression
of profilaggrin (D, E, F) and loricrin (J, K, L) mRNA was detected by in situ
hybridization at day 17 (D, J), day 19 (E, K), and day 21 (F, L).
Immunohistochemical localization of profilaggrin/filaggrin protein at day 17
(G), day 19 (H), and day 21 (I). The dotted line demarks the basal lamina of
the epidermis. The arrows indicate the stratum granulosum/stratum corneum
interface. Notice that whereas the mRNA are not detectable in the stratum
corneum, profilaggrin/filaggrin protein is present both in the upper stratum
granulosum and in the stratum corneum. Scale bar: 50 µm.
the specificity of hybridization. Omitting the DIG-labeled probes resulted in
no signal, indicating that only DIG-containing RNA hybrids were detected.
The sense control loricrin probe resulted in no signal, indicating the specificity
of hybridization with the anti-sense probe (not shown). Anti-sense profilaggrin
probe resulted in staining not only in the upper epidermal layers, as expected,
but in a variable staining of the basal cells at days 17 and 18, and in weak
staining of dermis. The use of the sense control profilaggrin probe, however,
showed that whereas the staining of the upper epidermis was due to specific
RNA–RNA hybrid formation, the signal seen in the basal layer and in the
dermis was a result of nonspecific interaction of the anti-sense probe with
unrelated endogenous mRNA.
Immunohistochemistry A rabbit anti-peptide antibody specific for mouse
loricrin (BabCo, Berkeley, CA) was found to cross-react with rat loricrin and
was therefore used to detect loricrin. A rabbit antibody (gift from Dr. B. Dale),
specific for rat profilaggrin and filaggrin, was used to localize profilaggrin and
filaggrin. The binding of the first antibodies was detected by biotinylated anti-
rabbit IgG, followed ABC reagent (Dako, Carpinteria, CA). Peroxidase activity
was revealed with DAB as substrate. Omitting the first antibodies resulted in
no signal, indicating the specificity of the immunodetection.
RESULTS
Characterization of profilaggrin/filaggrin and loricrin expres-
sion during in utero development and in fetal skin explants As
described previously (Hanley et al, 1996a), the epidermis displayed
dramatic changes during the last 4 d of gestation (from day 17 until
day 21). Whereas on day 17 of gestation, the fetal epidermis consisted
of only 2–3 cell layers, covered by a flattened layer of periderm
(Fig 1A), on day 19 the epidermis had more cell layers with the cells
containing keratohyalin granules in the upper layers (Fig 1B). A thin
layer of stratum corneum was also present. On day 21 of gestation the
epidermis was fully developed, with a mature basal, spinous, and
granular layer, and the stratum corneum consisted of multiple layers of
corneocytes (Fig 1C). In situ hybridization showed that these morphol-
ogic changes were accompanied by changes in expression of profilaggrin
and loricrin mRNA. Whereas expression of profilaggrin (Fig 1D) and
loricrin (Fig 1J) mRNA was not observed at day 17 of gestation, by
day 19 mRNA for both were present in the upper layers of the
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Figure 2. Development of fetal skin explants parallels in utero epidermal
differentiation. Hematoxylin and eosin stained sections of the epidermis,
collected on day 17 of in utero development, after 1 d (A) or 4 d (B) in culture.
Expression of profilaggrin (C, D) and loricrin (E, F) mRNA was detected by
in situ hybridization in explants cultured for 1 d (C, E) or 4 d (D, F). The
dotted line demarks the basal lamina of the epidermis. Scale bar: 50 µm.
epidermis (Figs 1E, K). Moreover, at day 21 of gestation mRNA for
profilaggrin (Fig 1F) and loricrin (Fig 1L) became even more abundant.
Not only did the number of cell layers expressing these messages
increase, but also individual cells showed a greater staining intensity
than earlier in gestation. The cells of the stratum corneum, however,
did not contain profilaggrin or loricrin mRNA (Figs 1F, L). Similar
changes in the expression of profilaggrin/filaggrin and loricrin proteins
were observed by immunohistochemical detection of these proteins
with specific antibodies. Whereas at day 17 of gestation no detectable
protein was observed (Fig 1G), by day 19 the upper layers of the
epidermis contained both profilaggrin/filaggrin (Fig 1H) and loricrin,
and by day 21 there was increased staining (Fig 1I) in both granular
cells and the stratum corneum (loricrin data not shown).
We next determined the time of appearance of these differentiation
markers in our fetal skin explant model. After 1 or 2 d in culture
(chronologic age 17 1 1 or 17 1 2 d), no detectable levels of
expression of profilaggrin/filaggrin or loricrin were observed by either
in situ hybridization or immunohistochemistry (Figs 2C, E). By 4 d
in culture (chronologic age 17 1 4 d), however, the epidermis
developed further, with the appearance of both granular keratinocytes
and a multilayered stratum corneum (Fig 2B), as described previously
(Hanley et al, 1996a, b). The suprabasal keratinocytes in the explants
cultured for 4 d (chronologic age 17 1 4 d) expressed substantial
amounts of profilaggrin and loricrin mRNA (Figs 2D, F) as well as
profilaggrin/filaggrin and loricrin proteins, although signal intensity
was not as pronounced as in utero at 21 d of gestation.
Thyroid hormone and glucocorticoids accelerate profilaggrin/
filaggrin and loricrin expression in fetal skin explants As
described above, fetal skin explants after 2 d in culture expressed no
detectable amounts of profilaggrin/filaggrin or loricrin; however, the
addition of either thyroid hormone or glucocorticoids to the medium
for 2 d resulted in the development of a stratified epidermis, with a
prominent granular layer and a thin layer of corneocytes (Figs 3B,
C), as described previously (Hanley et al, 1996a). Moreover, profilaggrin
and loricrin mRNA appeared in explants following either thyroid
hormone (Figs 3D, G versus E, H) or glucocorticoid (Figs 3D, G
versus F, I) treatment. Furthermore, the immunostaining for both
profilaggrin/filaggrin (Fig 3J versus K, L) and loricrin (not shown)
increased with either thyroid hormone or glucocorticoid treatment.
Yet, both of these hormones appeared to modulate loricrin expression
Figure 3. Thyroid hormone and glucocorticoids accelerate epidermal
differentiation in vitro. Explants collected on day 17 of in utero development
were cultured for 2 d with vehicle (control, left column) or in the presence
of thyroid hormone (middle column) or dexamethasone (right column).
Morphologic changes are shown in hematoxylin and eosin stained sections of
control (A), thyroid hormone treated (B), or dexamethasone treated (C)
explants. Expression of profilaggrin (D, E, F) and loricrin (G, H, I) mRNA
was detected by in situ hybridization after 2 d in culture in control explants (D,
G), or in the presence of thyroid hormone (E, H) or dexamethasone (F, I).
The presence of profilaggrin/filaggrin proteins was detected by immuno-
histochemistry in control explants (J), or in thyroid hormone (K) or
dexamethasone (L) treated explants. The dotted line demarks the basal lamina
of the epidermis. The arrows indicate the stratum granulosum/stratum corneum
interface. Notice that whereas the mRNA are not detectable in the stratum
corneum, profilaggrin/filaggrin proteins are present both in the upper stratum
granulosum and in the stratum corneum. Scale bar: 50 µm.
more than profilaggrin/filaggrin expression (Fig 3E versus H, and F
versus I), and thyroid hormone, at these doses, appeared to have a
more robust effect than glucocorticoid treatment (Fig 3E, H versus F,
I). Thus, in addition to stimulating permeability barrier development,
both thyroid hormone and glucocorticoids stimulate the expression of
structural proteins required for stratum corneum formation.
Estrogen accelerates, whereas dihydrotestosterone delays profi-
laggrin/filaggrin and loricrin expression in fetal skin explants
We next studied the effect of the sex steroid hormones, estrogen and
dihydrotestosterone, on epidermal keratinocyte differentiation in the
in vitro fetal skin explant model. As described previously (Hanley et al,
1996b), in vitro estrogen treatment for 2 d (chronologic age 17 1 2 d)
accelerated the appearance of a multilayered epidermis with granular
keratinocytes and a thin layer of corneocytes (Fig 4B). Profilaggrin
and loricrin mRNA were readily seen in the outer epidermis of
estrogen-treated explants (Figs 4E, H). Furthermore, immunostaining
for both profilaggrin/filaggrin and loricrin protein was also increased
following estrogen treatment (not shown). In contrast, dihydrotestoster-
one treatment delayed development of the stratum corneum, even
after 4 d (chronologic age 17 1 4 d) in culture (Fig 4C). Following
dihydrotestosterone treatment for 2 d (chronologic age 17 1 2 d),
neither the mRNA nor the proteins for profilaggrin/filaggrin and
loricrin were detectable (not shown). Although explants treated with
dihydrotestosterone for 4 d (chronologic age 17 1 4 d) showed some
signs of stratum corneum development, as well as profilaggrin and
loricrin expression, the staining intensity was weaker than in control
explants cultured for 4 d (Figs 4C, F, I). Together, these observations
indicate that both profilaggrin/filaggrin and loricrin expression are
stimulated by estrogen treatment, whereas dihydrotestosterone delays
expression of these structural proteins.
PPARa or FXR activators accelerate profilaggrin/filaggrin and
loricrin expression in fetal skin explants As reported previously
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Figure 4. Estrogens accelerate whereas dihydrotestosterone delays
epidermal differentiation in vitro. Explants collected on day 17 of in utero
development were cultured for 2 d with vehicle (control, left column) or in
the presence of estrogen (diethylstilbestrol; middle column), or for 4 d in the
presence of dihydrotestosterone (right column). Morphologic changes are shown
on hematoxylin and eosin stained sections of control (A), estrogen treated (B),
or dihydrotestosterone treated (C) explants. Expression of profilaggrin (D, E,
F) and loricrin (G, H, I) mRNA was detected by in situ hybridization in
control explants (D, G), or in the presence of diethylstilbestrol (E, H) or
dihydrotestosterone (F, I). The dotted line demarks the basal lamina of the
epidermis. Scale bar: 50 µm.
Figure 5. Activators of PPARa (clofibrate) and FXR (juvenile hormone
III) accelerate epidermal differentiation in vitro. Explants collected on day
17 of in utero development were cultured for 2 d in the presence of vehicle
(control, left column), clofibrate (middle column), or juvenile hormone III
(right column). Morphologic changes in the epidermis, after 2 d in culture
(control, A), or in the presence of clofibrate (B) or juvenile hormone III (C),
are shown in hematoxylin and eosin stained sections. Expression of profilaggrin
(D, E, F) and loricrin (G, H, I) was detected by in situ hybridization in control,
untreated (D, G), and clofibrate (E, H) or juvenile hormone III (F, I) treated
explants after 2 d in culture. Immunohistochemical localization of loricrin
protein in control (J), and clofibrate (K) or juvenile hormone III (L) treated
explants after 2 d in culture. The dotted line demarks the basal lamina of
the epidermis. The arrows indicate the stratum granulosum/stratum corneum
interface. Notice that whereas the mRNA are not detectable in the stratum
corneum, loricrin protein is present both in the upper stratum granulosum and
in the stratum corneum. Scale bar: 50 µm.
(Hanley et al, 1997b), addition of clofibrate, a PPARα activator, or
juvenile hormone III, a FXR activator, to fetal skin explants for 2 d
(chronologic age 17 1 2 d) markedly accelerated fetal epidermal
development (Fig 5B, C). Again, intense staining for both profilaggrin
(Fig 5E, F) and loricrin (Fig 5H, I) mRNA occurred following 2 d
treatment with either clofibrate (Fig 5E, H) or juvenile hormone III
(Fig 5F, I). Furthermore, profilaggrin/filaggrin and loricrin protein
expression increased in comparison with the control explants (Fig 5J,
K, and L). Clofibrate appeared to exert a more pronounced effect on
profilaggrin mRNA expression than on loricrin expression (Fig 5E
versus H), whereas juvenile hormone III displayed an equally strong
effect on both profilaggrin and loricrin expression (Figs 5F, I). Finally,
at the doses employed, both PPARα or FXR activators exerted a
stronger effect on profilaggrin/filaggrin and loricrin expression than
any of the hormones assessed in this study. Thus, activators of PPARα
or FXR accelerate not only fetal permeability barrier ontogenesis
(Hanley et al, 1997b), but also fetal epidermal development.
DISCUSSION
Adult mammalian epidermis is a stratified squamous epithelium, with
a basal layer of proliferating cells surmounted by several layers of
progressively differentiating, postmitotic suprabasal cells. The differenti-
ation of keratinocytes in the epidermis is a complex process involving
the sequential expression of structural proteins (Fuchs, 1990; Eckert
et al, 1997). This study and those published previously by us (Aszterbaum
et al, 1992, 1993; Hanley et al, 1996a, b, 1997b, c) and others
(Bickenbach et al, 1995) suggest that during normal fetal development
the formation of keratohyalin granules, cornified envelope, and the
extracellular lamellar lipid membranes of the stratum corneum occur
in parallel, suggesting coordinated regulation of these processes. In
intrauterine growth-retarded fetal rats, however, expression of
cornification markers is decreased and the formation of the permeability
barrier proceeds normally (Hoath et al, 1990; Williams et al, 1993). In
contrast, in mice that express an retinoic acid receptor dominant
negative mutant in the suprabasal epidermis, cornification proceeds
normally, but formation of the lamellar membranes is impaired (Imakado
et al, 1995). These observations suggest that discordant regulation
of epidermal keratinocyte differentiation could occur under certain
circumstances.
In this study we demonstrate that several ligands/activators of nuclear
hormone receptors (Isseman and Green, 1990; Forman et al, 1995;
Mangelsdorf et al, 1995), which we previously showed to regulate
permeability barrier formation, also regulate the expression of key
cytoplasmic constituents of the corneocyte and cornified envelope
synthesis. Specifically, in previous studies we demonstrated that gluco-
corticoids, thyroid hormone, estrogens, PPARα activators, and FXR
activators all accelerate formation of the permeability barrier as measured
by decreases in transepidermal water loss, the assembly of mature
extracellular lamellar membranes in the stratum corneum, and increased
activity of enzymes required for normal lipid processing (Hanley et al,
1996a, b, 1997b, c). In this study, we demonstrate that these same
hormones and nuclear receptor activators also accelerate the expression
of profilaggrin, a major protein constituent of keratohyalin granules,
and its processing to filaggrin, and the expression of loricrin, a key
structural protein of the cornified envelope. In our in vitro fetal skin
explant model, the addition of these hormones and activators resulted
in increased expression of both profilaggrin and loricrin mRNA
and profilaggrin/filaggrin and loricrin protein, measured by in situ
hybridization and by immunohistochemistry. Moreover, dihydrotesto-
sterone, which in previous studies delayed the formation of the
permeability barrier (Hanley et al, 1996b), here also delayed the
expression of profilaggrin and loricrin. Our results demonstrate that
these hormones and activators of nuclear hormone receptors (Isseman
and Green, 1990; Forman et al, 1995; Mangelsdorf et al, 1995)
coordinately regulate keratinocyte differentiation. This observation
suggests that these nuclear hormone receptor ligands and activators,
which are required for normal epidermal differentiation (Imakado et al,
1995; Saitou et al, 1995; Feng et al, 1997), probably affect early,
fundamental processes. Whether these nuclear receptors directly
increase profilaggrin and loricrin mRNA expression or act via stimulat-
ing other transcription factors remains to be determined.
We have demonstrated that a number of different hormones and
nuclear receptor activators can stimulate epidermal differentiation
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during fetal development. The physiologic role of each of these
hormones and activators in regulating stratum corneum development
and whether they do so independently or by effecting each other
remains to be determined. In recent studies using animals deficient in
specific hormones we have begun to address the importance of these
hormones in fetal stratum corneum development. In Hyt/Hyt mice,
which are hypothyroid due to a mutation in the TSH receptor (Beamer
et al, 1981; Stein et al, 1991), stratum corneum formation is delayed
but by birth the stratum corneum is normal (Hanley et al, 1997a).
Similarly, in corticotropin releasing factor deficient mice, who are
glucocorticoid deficient, stratum corneum formation is also delayed
but again by birth the stratum corneum is normal (unpublished
observations). This suggests that both thyroid hormone and glucocort-
icoids play an important role in stratum corneum ontogenesis but that
neither hormone is absolutely essential, i.e., a normal stratum corneum
will ultimately form, but develops at a slower rate. Interestingly,
treatment of hypothyroid mice with glucocorticoids did not result in
the usual stimulation of stratum corneum formation, suggesting that
glucocorticoids may regulate stratum corneum development by modu-
lating thyroid hormone response or that glucocorticoids require the
euthyroid state in order to be effective (Hanley et al, 1997a). Further
studies delineating the physiologic importance of these hormones
and their interactions in regulating stratum corneum development
are required.
In summary, this study demonstrates that hormones (glucocorticoids,
thyroid hormone, and estrogen), PPARα activators (clofibrate), and
FXR activators (juvenile hormone III) not only accelerate permeability
barrier formation during fetal development but also accelerate profilag-
grin/filaggrin and loricrin expression, indicating that these nuclear
hormone receptor ligands and activators coordinately regulate kerato-
hyalin granule, cornified envelope, and stratum corneum extracellular
lamellar membrane ontogenesis.
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